FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL)